Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.verified

AURX

Price:

$2.26

Market Cap:

$108.66M

Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.

Industry

Biotechnology

IPO Date

2017-10-24

Stock Exchange

OTC

Ticker

AURX

The PE Ratio as of December 2025 (TTM) for Nuo Therapeutics, Inc. (AURX) is -45.20

According to Nuo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -45.20. This represents a change of 45.91% compared to the average of -30.98 of the last 4 quarters.

Nuo Therapeutics, Inc. (AURX) Historical PE Ratio (quarterly & annually)

How has AURX PE Ratio performed in the past?

The mean historical PE Ratio of Nuo Therapeutics, Inc. over the last ten years is -14.09. The current -45.20 PE Ratio has changed 31.98% with respect to the historical average. Over the past ten years (40 quarters), AURX's PE Ratio was at its highest in in the December 2019 quarter at 12.29. The PE Ratio was at its lowest in in the March 2021 quarter at -793.36.

Quarterly (TTM)
Annual

Average

-14.09

Median

-1.36

Minimum

-83.02

Maximum

0.13

Nuo Therapeutics, Inc. (AURX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Nuo Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 59.26%

Maximum Annual PE Ratio = 0.13

Minimum Annual Increase = -195.94%

Minimum Annual PE Ratio = -83.02

Quarterly (TTM)
Annual
YearPE RatioChange
2024-27.37275.04%
2023-7.30-63.21%
2022-19.8359.26%
2021-0.03-99.96%
2020-83.024.03%
2019-2.01232.80%
2018-0.60375.10%
2017-0.13-195.94%
20160.13-118.52%
2015-0.72-62.63%

Nuo Therapeutics, Inc. (AURX) Average PE Ratio

How has AURX PE Ratio performed in the past?

The current PE Ratio of Nuo Therapeutics, Inc. (AURX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-18.17

5-year avg

-27.51

10-year avg

-14.09

Nuo Therapeutics, Inc. (AURX) PE Ratio vs. Peers

How is AURX’s PE Ratio compared to its peers?

Nuo Therapeutics, Inc.’s PE Ratio is less than Kintor Pharmaceutical Limited (0), less than Paradigm Biopharmaceuticals Limited (-7.47), less than Poolbeg Pharma PLC (-3.30), less than Hofseth BioCare ASA (-4.79), less than Satellos Bioscience Inc. (-1.76), less than VitaSpring Biomedical Co. Ltd. (162.96), less than Imugene Limited (-1.02), less than Green Growth Brands Inc. (-0.00), less than AVITA Medical, Inc. (-1.83), less than Starpharma Holdings Limited (-16.54),

Build a custom stock screener for Nuo Therapeutics, Inc. (AURX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuo Therapeutics, Inc. (AURX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Nuo Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Nuo Therapeutics, Inc. (AURX)?

What is the highest PE Ratio for Nuo Therapeutics, Inc. (AURX)?

What is the 3-year average PE Ratio for Nuo Therapeutics, Inc. (AURX)?

What is the 5-year average PE Ratio for Nuo Therapeutics, Inc. (AURX)?

How does the current PE Ratio for Nuo Therapeutics, Inc. (AURX) compare to its historical average?